251 related articles for article (PubMed ID: 26992667)
1. Decreased placental and maternal serum TRAIL-R2 levels are associated with placenta accreta.
Oztas E; Ozler S; Ersoy AO; Ersoy E; Caglar AT; Uygur D; Yucel A; Ergin M; Danisman N
Placenta; 2016 Mar; 39():1-6. PubMed ID: 26992667
[TBL] [Abstract][Full Text] [Related]
2. First trimester serum PAPP-A is associated with placenta accreta: a retrospective study.
Wang F; Chen S; Wang J; Wang Y; Ruan F; Shu H; Zhu L; Man D
Arch Gynecol Obstet; 2021 Mar; 303(3):645-652. PubMed ID: 33515274
[TBL] [Abstract][Full Text] [Related]
3. Fraction of cell-free fetal DNA in the maternal serum as a predictor of abnormal placental invasion-a pilot study.
Samuel A; Bonanno C; Oliphant A; Batey A; Wright JD
Prenat Diagn; 2013 Nov; 33(11):1050-3. PubMed ID: 23836321
[TBL] [Abstract][Full Text] [Related]
4. Maternal plasma levels of cell-free β-HCG mRNA as a prenatal diagnostic indicator of placenta accrete.
Zhou J; Li J; Yan P; Ye YH; Peng W; Wang S; Wang XT
Placenta; 2014 Sep; 35(9):691-5. PubMed ID: 25063251
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of serum IL-33 is associated with adverse maternal outcomes in placenta previa accreta.
Ozler S; Oztas E; Guler BG; Caglar AT
J Matern Fetal Neonatal Med; 2021 Oct; 34(19):3192-3199. PubMed ID: 31608786
[TBL] [Abstract][Full Text] [Related]
6. First trimester serum PIGF is associated with placenta accreta.
Wang F; Zhang L; Zhang F; Wang J; Wang Y; Man D
Placenta; 2020 Nov; 101():39-44. PubMed ID: 32916477
[TBL] [Abstract][Full Text] [Related]
7. Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein.
Zelop C; Nadel A; Frigoletto FD; Pauker S; MacMillan M; Benacerraf BR
Obstet Gynecol; 1992 Oct; 80(4):693-4. PubMed ID: 1383899
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing placenta accreta from placenta previa via maternal plasma levels of sFlt-1 and PLGF and the sFlt-1/PLGF ratio.
Zhang F; Gu M; Chen P; Wan S; Zhou Q; Lu Y; Li L
Placenta; 2022 Jun; 124():48-54. PubMed ID: 35635854
[TBL] [Abstract][Full Text] [Related]
9. Expression of Cripto-1 in the placenta and its role in placenta accreta and placenta previa.
Jiang L; Wu X; Yan J; Chen R; Han Q; Zhang Q
Ginekol Pol; 2019; 90(2):86-92. PubMed ID: 30860275
[TBL] [Abstract][Full Text] [Related]
10. Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast.
Wehrum MJ; Buhimschi IA; Salafia C; Thung S; Bahtiyar MO; Werner EF; Campbell KH; Laky C; Sfakianaki AK; Zhao G; Funai EF; Buhimschi CS
Am J Obstet Gynecol; 2011 May; 204(5):411.e1-411.e11. PubMed ID: 21316642
[TBL] [Abstract][Full Text] [Related]
11. Maternal serum markers, characteristics and morbidly adherent placenta in women with previa.
Lyell DJ; Faucett AM; Baer RJ; Blumenfeld YJ; Druzin ML; El-Sayed YY; Shaw GM; Currier RJ; Jelliffe-Pawlowski LL
J Perinatol; 2015 Aug; 35(8):570-4. PubMed ID: 25927270
[TBL] [Abstract][Full Text] [Related]
12. Cryopreserved embryo transfer is an independent risk factor for placenta accreta.
Kaser DJ; Melamed A; Bormann CL; Myers DE; Missmer SA; Walsh BW; Racowsky C; Carusi DA
Fertil Steril; 2015 May; 103(5):1176-84.e2. PubMed ID: 25747133
[TBL] [Abstract][Full Text] [Related]
13. In vitro fertilization as an independent risk factor for placenta accreta spectrum.
Salmanian B; Fox KA; Arian SE; Erfani H; Clark SL; Aagaard KM; Detlefs SE; Aalipour S; Espinoza J; Nassr AA; Gibbons WE; Shamshirsaz AA; Belfort MA; Shamshirsaz AA
Am J Obstet Gynecol; 2020 Oct; 223(4):568.e1-568.e5. PubMed ID: 32360847
[TBL] [Abstract][Full Text] [Related]
14. Increased level of cell-free placental mRNA in a subgroup of placenta previa that needs hysterectomy.
Miura K; Miura S; Yamasaki K; Yoshida A; Yoshiura K; Nakayama D; Niikawa N; Masuzaki H
Prenat Diagn; 2008 Sep; 28(9):805-9. PubMed ID: 18646248
[TBL] [Abstract][Full Text] [Related]
15. [Placenta accreta with placenta previa after previous cesarean sections--a growing danger in modern obstetrics].
Lachman E; Mali A; Gino G; Burstein M; Stark M
Harefuah; 2000 Apr; 138(8):628-31, 712. PubMed ID: 10883200
[TBL] [Abstract][Full Text] [Related]
16. Human placental lactogen mRNA in maternal plasma play a role in prenatal diagnosis of abnormally invasive placenta: yes or no?
Li J; Zhang N; Zhang Y; Hu X; Gao G; Ye Y; Peng W; Zhou J
Gynecol Endocrinol; 2019 Jul; 35(7):631-634. PubMed ID: 30784325
[No Abstract] [Full Text] [Related]
17. A prior placenta accreta is an independent risk factor for post-partum hemorrhage in subsequent gestations.
Vinograd A; Wainstock T; Mazor M; Mastrolia SA; Beer-Weisel R; Klaitman V; Dukler D; Hamou B; Benshalom-Tirosh N; Vinograd O; Erez O
Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():20-4. PubMed ID: 25681995
[TBL] [Abstract][Full Text] [Related]
18. An analysis of placental chorionic villous and decidual basalis tissue immunoreactivity in patients after cesarean section due to a placenta accreta spectrum disorder and elective cesarean section followed by the depressed mood.
Dutsch-Wicherek MM; Bączkowska M; Knafel A; Sadowski P; Gałązka K; Lew-Starowicz M
J Obstet Gynaecol Res; 2024 Jan; 50(1):55-64. PubMed ID: 37909688
[TBL] [Abstract][Full Text] [Related]
19. Assessment of serum levels and placental bed tissue expression of IGF-1, bFGF, and PLGF in patients with placenta previa complicated with placenta accreta spectrum disorders.
Arakaza A; Liu X; Zhu J; Zou L
J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2305264. PubMed ID: 38247274
[TBL] [Abstract][Full Text] [Related]
20. The risk of placenta accreta following primary elective caesarean delivery: a case-control study.
Kamara M; Henderson JJ; Doherty DA; Dickinson JE; Pennell CE
BJOG; 2013 Jun; 120(7):879-86. PubMed ID: 23448347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
